Sponsor Pipeline

Qanatpharma AG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07695090 Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients Heart Failure With Reduced Ejection Fraction Recruiting
Disease Areas
Heart Failure (1)
Get alerts when Qanatpharma AG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free